Stock listing
NASDAQ:DMTX Dimension Therapeutics Stock
Follow Dimension Therapeutics into a list and get an email when it puts out news.
Last close · NASDAQ:DMTX
$5.95 USD
Close on Nov 6, 2017 · No longer trades
- Lowest – highest close
- $1.05 – $15.35 USDSince Oct 22, 2015 · lowest May 26, 2017 · highest Dec 1, 2015
Delisted NASDAQ:DMTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:DMTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Dimension Therapeutics on 6ix
- Decks
- 3 decks · latest Aug 25, 2017
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (August 2017) | Merger or acquisition | 35 slides | Aug 25, 2017 |
| Investor Presentation (January 2017) | Investor deck | 28 slides | Jan 31, 2017 |
| Investor Presentation (August 2016) | Investor deck | 21 slides | Aug 11, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Annalisa Jenkins Other companies: Skye Bioscience, Inc. (Director · Since at least Feb 29, 2024); Mereo BioPharma Group plc (Director · Since at least Jan 1, 2024); COMPASS Pathways Plc (Director · Since at least Jan 1, 2022); Serina Therapeutics, Inc. (Director · Nov 27, 2018 – Jun 21, 2021 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 6, 2023 · Past); Ardelyx, Inc. (Director · Apr 20, 2015 – Jun 13, 2019 · Past) | President and CEO, Director · Oct 21, 2015 – Nov 7, 2017 · Past |
| John Hohneker Other companies: ArriVent BioPharma, Inc. (Director · Since at least May 16, 2024); Curis, Inc. (Director · Since at least Dec 2, 2021); Carisma Therapeutics, Inc. (Director · Apr 1, 2024 – Jun 26, 2024 · Past); Humanigen Inc (Director · Oct 19, 2021 – Jul 27, 2022 · Past); Aravive Inc (Director · May 12, 2021 – Sep 23, 2022 · Past); Evelo Biosciences, Inc. (Director · Jan 27, 2021 – Jun 8, 2023 · Past) | Director · Jan 18, 2017 – Nov 7, 2017 · Past |
| Mary Thistle Other companies: Aktis Oncology, Inc. (Independent Director · Since at least Jan 8, 2026); Cullinan Therapeutics, Inc. (Chair of the Compensation Committee · Since at least Aug 8, 2024); Vigil Neuroscience Inc (Director · Since at least Apr 18, 2022); Entrada Therapeutics, Inc. (Industry Leader and Independent Director · Since at least Oct 28, 2021); Q32 Bio Inc. (Director · Since at least Mar 27, 2018); Alaunos Therapeutics, Inc. (Director · Nov 15, 2020 – Jun 6, 2023 · Past) | Chief Operating Officer · Feb 1, 2017 – Nov 7, 2017 · Past |
| Michael Dybbs Other companies: SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Kalaris Therapeutics, Inc. (Director · Since at least Mar 18, 2025); Nkarta, Inc. (Director · Since at least Jul 9, 2020); Sutro Biopharma, Inc. (Member, Board of Directors · Since at least Sep 26, 2018) | Director · Oct 21, 2015 – Nov 7, 2017 · Past |
Log in to ask 6ix AI your own questions about Dimension Therapeutics.